WealthPLAN Partners’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-15	Closed	-$10.4K	–	348
2023 Q3	$10.4K	Buy	15 +2	+15%	+$8.57K	﹤0.01%	314
2023 Q2	$60.3K	Sell	13 -6	-32%	-$20.8K	0.01%	480
2023 Q1	$50.9K	Sell	19 -1	-5%	-$2.93K	0.01%	551
2022 Q4	$55.1K	Buy	+20	New	+$69.7K	﹤0.01%	387
2022 Q1	$33K	Hold	14	–	–	﹤0.01%	379
2021 Q4	$60K	Buy	14 +2	+17%	+$15.4K	﹤0.01%	375
2021 Q3	$84K	Buy	12 +3	+33%	+$25.8K	0.01%	370
2021 Q2	$78K	Buy	9 +4	+80%	+$65.7K	0.01%	353
2021 Q1	$117K	Hold	5	–	–	0.01%	328
2020 Q4	$57K	Hold	5	–	–	﹤0.01%	330
2020 Q3	$18K	Hold	5	–	–	﹤0.01%	312
2020 Q2	$21K	Hold	5	–	–	﹤0.01%	307
2020 Q1	$15K	Hold	5	–	–	﹤0.01%	252
2019 Q4	$16K	Hold	5	–	–	﹤0.01%	246
2019 Q3	$14K	Buy	5 +2	+67%	+$12.1K	﹤0.01%	233
2019 Q2	$17K	Buy	+3	New	+$31.6K	﹤0.01%	238